首页> 外文OA文献 >A Combined Epigenetic and Non-Genetic Approach for Reprogramming Human Somatic Cells
【2h】

A Combined Epigenetic and Non-Genetic Approach for Reprogramming Human Somatic Cells

机译:表观遗传和非遗传相结合的方法来重编程人体细胞。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Reprogramming of somatic cells to different extents has been reported using different methods. However, this is normally accompanied by the use of exogenous materials, and the overall reprogramming efficiency has been low. Chemicals and small molecules have been used to improve the reprogramming process during somatic cell nuclear transfer (SCNT) and induced pluripotent stem (iPS) cell generation. We report here the first application of a combined epigenetic and non-genetic approach for reprogramming somatic cells, i.e., DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors, and human embryonic stem cell (hESC) extracts. When somatic cells were pretreated with these inhibitors before exposure to hESC (MEL1) extracts, morphological analysis revealed a higher rate of hESC-like colony formation than without pretreatment. Quantitative PCR (qPCR) demonstrated that pluripotency genes were upregulated when compared to those of somatic cells or treated with hESC extracts alone. Overall changes in methylation and acetylation levels of pretreated somatic cells suggests that epigenetic states of the cells have an effect on reprogramming efficiency induced by hESC extracts. KnockOutserum replacement (KOSR™) medium (KO-SR) played a positive role in inducing expression of the pluripotency genes. hESC extracts could be an alternative approach to reprogram somatic cells without introducing exogenous materials. The epigenetic pre-treatment of somatic cells could be used to improve the efficiency of reprogramming process. Under differentiation conditions, the reprogrammed cells exhibited differentiation ability into neurons suggesting that, although fully reprogramming was not achieved, the cells could be transdifferentiated after reprogramming.
机译:已经报道了使用不同方法将体细胞重编程至不同程度。然而,这通常伴随使用外源材料,并且总体重编程效率很低。化学物质和小分子已被用于改善体细胞核移植(SCNT)和诱导多能干(iPS)细胞生成过程中的重编程过程。我们在此报告表观遗传学和非遗传学方法相结合的首次应用,用于重编程体细胞,即DNA甲基转移酶(DNMT)和组蛋白脱乙酰基酶(HDAC)抑制剂以及人类胚胎干细胞(hESC)提取物。当在暴露于hESC(MEL1)提取物之前用这些抑制剂对体细胞进行预处理时,形态分析表明,与未进行预处理相比,hESC样菌落形成的速率更高。定量PCR(qPCR)证明,与体细胞或单独用hESC提取物处理相比,多能性基因上调。预处理的体细胞甲基化和乙酰化水平的总体变化表明,细胞的表观遗传状态对hESC提取物诱导的重编程效率有影响。敲除血清替代物(KOSR™)培养基(KO-SR)在诱导多能性基因的表达中发挥了积极作用。 hESC提取物可能是重新编程体细胞而不引入外源物质的替代方法。体细胞的表观遗传预处理可用于提高重编程过程的效率。在分化条件下,重编程的细胞表现出向神经元的分化能力,这表明,尽管不能完全重编程,但在重编程后细胞可以被转分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号